FDA to decide on Lykos' MDMA therapy for PTSD, offering hope for millions
The FDA is expected to make a pivotal decision on Sunday (August 11) regarding the approval of Lykos Therapeutics’ MDMA-assisted therapy for PTSD.
Archives for August 6, 2024
Red Queen Therapeutics debuts to tackle viral infections with $55M funding
Red Queen Therapeutics, a new clinical-stage biotechnology company, has launched with a mission to develop antiviral treatments for serious viral diseases, including coronaviruses, influenza, and respiratory syncytial virus (RSV).